Equity Details
Price & Market Data
Price: $64.20
Daily Change: -$0.10 / 0.16%
Daily Range: $62.89 - $66.36
Market Cap: $2,209,479,168
Daily Volume: 1,535,847
Performance Metrics
1 Week: -32.66%
1 Month: -43.60%
3 Months: -54.10%
6 Months: -46.35%
1 Year: -46.16%
YTD: -47.45%
About TransMedics Group, Inc. (TMDX)
A complete market overview for TransMedics Group, Inc. (TMDX). The stock is at 64.20, with a daily change of -$0.10 / 0.16%. Market cap: 2,209,479,168. Delve into its YTD and 3-month performance.
Company Details
Employees: 898
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.